Chicago Capital’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Chicago Capital's ABMD Position: Q4 2022 in Review
Chicago Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 125,636 shares — an estimated $30.9M sold.
Chicago Capital first reported a position in ABMD in Q1 2018 and held it in 19 quarters. The position peaked at $54.6M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Chicago Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Chicago Capital sold 125,636 Abiomed Inc shares in Q4 2022, an estimated $30.9M.
- Chicago Capital first reported a position in Abiomed Inc in Q1 2018 and held it in 19 quarters.
- Chicago Capital's Abiomed Inc position peaked at $54.6M in Q4 2021.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Chicago Capital's 13F filing for Q4 2022, filed 20 Jan 2023.